Sanofi backs '16 vaccine' effort to bolster meningitis awareness by Beth Snyder Bulik Monday, September 24, 2018 Last week, the National Meningitis Association, backed by Sanofi, launched "The 16 Vaccine” campaign to remind teens about a booster vaccine.
CHMP endorses Lilly's CGRP Emgality, Spark's Luxturna and more by Angus Liu Friday, September 21, 2018 Emgality will likely chase Amgen and Novartis’ first-in-class Aimovig and Teva's Ajovy in the CGRP migraine field.
Keytruda, Takeda and more—FiercePharmaAsia by Angus Liu Friday, September 21, 2018 Merck halves Keytruda's price in China; Takeda eyes selling Shire's Xiidra and Natpara; another ex-GSK scientist pleads guilty to trade secret theft.
GSK fails to warn of pandemic flu vaccine’s safety problem: BMJ by Angus Liu Thursday, September 20, 2018 After examining GSK's internal safety reports, The BMJ suggests serious safety signal had emerged for Pandemrix but was not made public.
AZ, shut out of COPD, touts long-term Fasenra asthma data by Carly Helfand Tuesday, September 18, 2018 AZ struck out in May in trying to expand Fasenra into COPD. But it does have new long-term data that could bolster the drug in its current indication.
GSK expands Canada plant, adds production of topical pain reliever by Eric Palmer Tuesday, September 18, 2018 GlaxoSmithKline has made a small investment in a manufacturing site in Canada in part to make an OTC pain reliever.
Pfizer, Novo, Novartis plants, unfazed by hurricane, resume production by Eric Palmer Monday, September 17, 2018 Drug manufacturers were shaking off the remnants of Hurricane Florence on Monday after the dangers from the storm morphed into hazardous flooding.
With new data, can AZ's COPD triple combo rival GSK's Trelegy? by Carly Helfand Monday, September 17, 2018 AstraZeneca’s latest data on its triple-combination COPD candidate may not do much to help it against rival GlaxoSmithKline.
Takeda, Sanofi and more—FiercePharmaAsia by Angus Liu Friday, September 14, 2018 A Takeda founder descendant blasts the Shire deal, as the company moves its U.S. HQ closer to Shire; Sanofi revamps two global units.
Novartis, Novo, Glaxo plants hunker down as hurricane sweeps in by Eric Palmer Thursday, September 13, 2018 As Hurricane Florence bore down on the U.S. Southeast today, drugmakers were taking steps to continue providing supplies and keep employees safe.
